Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO in ICU anemia feasibility study
2021-003770-30Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in anaemia comparing epoetin alfa with placebo (2 arms). Primary endpoint: Feasibility of a randomized controlled trial. Started Sep 2021; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anaemia
Beyond the preview
Go deeper on 2021-003770-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003770-30.